What is the Decitabine drug?
Decitabine is a chemical analog of cytidine, a nucleoside present in DNA and RNA. Decitabine drug is used for the treatment of myelodysplastic syndromes, and for acute myeloid leukemia. As a cancer medicine, Decitabine slows the growth and spread of cancer cells. In the US, the FDA approved the medical use of Decitabine in 2006.Decitabine manufacturers and wholesalers:
Decitabine's most known brand name is Dacogen by Otsuka Pharmaceuticals Co, Ltd. Some of Decitabine suppliers are Accord Healthcare, Cipla, and Chemi Spa. Decitabine suppliers market it in the form of lyophilized powder for solution for injection of 50 mg/20 ml or 50 mg/10ml.Decitabine for sales:
In the US, Dacogen powder for injection 50 mg can cost from $324.50 to $1706.4.How to use Decitabine drugs?
There are two ways to be administered Decitabine for treatment. The first one is 15 mg/m2 IV over 3 hours; the patient should repeat every 8 hours for three days and repeat this cycle every six weeks. The second one is 20 mg/m2 IV over 1 hour; the patient should repeat this daily for five days and repeat this cycle every four weeks. Taking Decitabine can cause some side effects, the most common ones include black, tarry stools, bladder pain, bleeding after defecation, bleeding gums, blood in the urine or stools, blue lips and fingernails.Popular Searches
Want unlimited access to the Pipelinepharma database?
Become a subscriber to unlock:
-
Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.
-
Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.
-
Higher profitability: compare multiple supplier offers and secure the best commercial terms.
-
Expanded network: view supplier portfolios and stay updated on new products.
-
Value-added product ideas: discover products with lower competition potential.
-
Access to marketing authorizations for sale: find already registered products in your target markets.